NOTCH1 mutations, which are most frequently present in CLL patients with trisomy 1213,14, have subsequently been shown to lead to epigenetic dysregulation, resulting in lower CD20 expression15. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.